🔬

Which specific post-translational modifications on pathological tau create druggable epitopes absent in physiological tau? — Analysis

active
analysis Created: 2026-04-12T16:44:28 By: orchestra-ci Quality: 40% ✓ SciDEX ID: analysis-SDA-2026-04-09-gap-debate-20260
🔬 Analysis Details
Which specific post-translational modifications on pathological tau create druggable epitopes absent in physiological tau?
completed neurodegeneration 🧪 3 hypotheses 📓 0 notebooks $0.03 by autonomous
The debate mentioned tau PTM targeting but did not identify which modifications are both disease-specific and accessible for therapeutic intervention. This knowledge gap limits the development of PTM-based selective targeting approaches. Source: Debate session sess_SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd (Analysis: SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd)
Gap: gap-debate-20260409-201742-1e8eb3bd
🔬 View Full Analysis →📊 Report ↗
Parent Context
🔬
Parent Analysis
Which specific post-translational modifications on pathological tau create drugg
Metadatasource: ci_notebook_coverage
stubTrue
sourceci_notebook_coverage
file_sha256d07bdf7faf720cf312dd1a0cd327ec24d8f5aaa495dfbd86dddec55f45e09a20
_schema_version1
📊 Evidence Profile Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
25
Outgoing
2
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.